These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 4818502)

  • 1. Proceedings: Comparison of the effects of mexiletine, lignocaine and procainamide on canine Purkinje fibres.
    Allen JD; Arnold JM
    J Physiol; 1974 Jan; 236(1):26P-28P. PubMed ID: 4818502
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
    Carmeliet E
    Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on the effects of selected antiarrhythmic drugs on mammalian cardiac purkinje fibers with two levels of steady-state potential: influences of lidocaine, phenytoin, propranolol, disopyramide and procainamide on repolarization, action potential shape and conduction.
    Arnsdorf MF; Mehlman DJ
    J Pharmacol Exp Ther; 1978 Dec; 207(3):983-91. PubMed ID: 731444
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of antiarrhythmic drugs on triggered sustained rhythmic activity in cardiac Purkinje fibers.
    Arnsdorf MF
    J Pharmacol Exp Ther; 1977 Jun; 201(3):689-700. PubMed ID: 577217
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative mechanisms of action of antiarrhythmic drugs.
    Singh BN; Hauswirth O
    Am Heart J; 1974 Mar; 87(3):367-82. PubMed ID: 4149610
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of lidocaine on conduction in canine Purkinje fibers and at the ventricular muscle-Purkinje fiber junction.
    Bigger JT; Mandel WJ
    J Pharmacol Exp Ther; 1970 Apr; 172(2):239-54. PubMed ID: 5441153
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of several anti-arrhythmia agents on excitability and conduction depressed by digitalis agents].
    Márquez M; Kabela E
    Arch Inst Cardiol Mex; 1984; 54(6):535-44. PubMed ID: 6241458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electrophysiologic study of antiarrhythmic agents in man].
    Puech P
    Arch Inst Cardiol Mex; 1977; 47(2):233-47. PubMed ID: 901058
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent advances in electrophysiology of antiarrhythmic drugs.
    Bassett AL; Wit AL
    Prog Drug Res; 1973; 17():33-58. PubMed ID: 4593392
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of antiarrhythmic drugs on the premature action potential duration in canine cardiac Purkinje fibers.
    Varro A; Elharrar V; Surawicz B
    J Pharmacol Exp Ther; 1985 May; 233(2):304-11. PubMed ID: 3999021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mode of action of antiarrhythmic drugs (author's transl)].
    Sano T
    Kokyu To Junkan; 1974 Apr; 22(4):321-6. PubMed ID: 4603686
    [No Abstract]   [Full Text] [Related]  

  • 13. Frequency-dependent effects of several class I antiarrhythmic drugs on Vmax of action potential upstroke in canine cardiac Purkinje fibers.
    Varro A; Elharrar V; Surawicz B
    J Cardiovasc Pharmacol; 1985; 7(3):482-92. PubMed ID: 2410678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrophysiological principles of the action of antiarrhythmia agents].
    Sanna GP; Lomanto B; Rossi A
    Minerva Cardioangiol; 1974 Nov; 22(11):731-58. PubMed ID: 4453368
    [No Abstract]   [Full Text] [Related]  

  • 15. The development of new antidysrhythmic drugs.
    Williams EM
    Schweiz Med Wochenschr; 1973 Feb; 103(8):262-71. PubMed ID: 4144416
    [No Abstract]   [Full Text] [Related]  

  • 16. [Electrophysiologic effects of changrolin on the cardiac conduction system in anesthetized rabbits].
    Yu Y; Yu FS; Gu PK; Jin ZJ
    Zhongguo Yao Li Xue Bao; 1987 Sep; 8(5):421-5. PubMed ID: 3450179
    [No Abstract]   [Full Text] [Related]  

  • 17. Mexiletine and tocainide: orally active congeners of lidocaine.
    Wulf BG
    Clin Pharm; 1983; 2(4):340-6. PubMed ID: 6411416
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential effects of procainamide, lidocaine and acetylstrophanthidin on body surface potentials and epicardial conduction in dogs with chronic myocardial infarction.
    de Langen CD; Hanich RF; Michelson EL; Kadish AH; Levine JH; Balke CW; Spear JF; Moore EN
    J Am Coll Cardiol; 1988 Feb; 11(2):403-13. PubMed ID: 3339181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the effects of disopyramide and procainamide on auriculo-ventricular conduction in dogs under chloralose].
    Duchêne-Marullaz P; Schaff G; Lapalus P; Lautier F; Lavarenne P
    C R Seances Soc Biol Fil; 1970 Sep; 164(2):327-9. PubMed ID: 4249123
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmacology of cardio-active agents.
    Hayes AH
    Cardiovasc Clin; 1972; 4(3):103-18. PubMed ID: 4130206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.